These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20594986)

  • 1. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.
    Gligorov J; Bastit L; Gervais H; Henni M; Kahila W; Lepille D; Luporsi E; Sasso G; Varette C; Azria D;
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):532-9. PubMed ID: 20594986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
    Studena V; Sycova Z; Helpianska L; Sorkovska D; Pichna P; Lacka J; Hlavacova E; Oravcova E; Krcmery V; Studena M
    J Chemother; 1995 Nov; 7 Suppl 4():204-5. PubMed ID: 8904157
    [No Abstract]   [Full Text] [Related]  

  • 5. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
    Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miconazole (Oravig) for oropharyngeal candidiasis.
    Med Lett Drugs Ther; 2010 Nov; 52(1352):95-6. PubMed ID: 21116234
    [No Abstract]   [Full Text] [Related]  

  • 7. Oropharyngeal candidiasis: a new treatment option.
    Klotz SA
    Clin Infect Dis; 2006 Apr; 42(8):1187-8. PubMed ID: 16575740
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748
    [No Abstract]   [Full Text] [Related]  

  • 9. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    Horn CA; Washburn RG; Givner LB; Peacock JE; Pegram PS
    AIDS; 1995 May; 9(5):533-4. PubMed ID: 7639986
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
    Finlay PM; Richardson MD; Robertson AG
    Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
    Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective evaluation of oropharyngeal findings in human immunodeficiency virus-infected patients with esophageal ulceration.
    Wilcox CM; Straub RF; Clark WS
    Am J Gastroenterol; 1995 Nov; 90(11):1938-41. PubMed ID: 7484995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidiasis: pathogenesis, clinical characteristics, and treatment.
    Appleton SS
    J Calif Dent Assoc; 2000 Dec; 28(12):942-8. PubMed ID: 11323949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
    Darouiche RO
    Clin Infect Dis; 1998 Feb; 26(2):259-72; quiz 273-4. PubMed ID: 9502438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
    Fernández Fernández A; Esteban Montero S
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
    [No Abstract]   [Full Text] [Related]  

  • 16. Oropharyngeal candidiasis treated with a troche form of clotrimazole.
    Yap BS; Bodey GP
    Arch Intern Med; 1979 Jun; 139(6):656-7. PubMed ID: 375858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer.
    Bensadoun RJ; Daoud J; El Gueddari B; Bastit L; Gourmet R; Rosikon A; Allavena C; Céruse P; Calais G; Attali P
    Cancer; 2008 Jan; 112(1):204-11. PubMed ID: 18044772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey.
    Belgioia L; Bacigalupo A; Alterio D; Russi E; Corvò R
    Tumori; 2015; 101(3):312-7. PubMed ID: 25908051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.
    Fukushima C; Matsuse H; Tomari S; Obase Y; Miyazaki Y; Shimoda T; Kohno S
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):646-51. PubMed ID: 12839324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between CD4 count and intensity of Candida colonization in the oropharynx of HIV-infected/ AIDS patient.
    Bandar IN; Widodo D; Djauzi S; Muthalib A; Soegondo S; Wahyuningsih R
    Acta Med Indones; 2006; 38(3):119-25. PubMed ID: 16953027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.